Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis.

FitzGerald AJ, Pu M, Marchbank T, Westley BR, May FE, Boyle J, Yadollahi-Farsani M, Ghosh S, Playford RJ.

Peptides. 2004 May;25(5):793-801.

PMID:
15177874
2.

The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.

Yadollahi-Farsani M, Davies DS, Boobis AR.

Carcinogenesis. 2002 Nov;23(11):1947-52.

PMID:
12419845
3.

Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase.

Saxty BA, Yadollahi-Farsani M, Upton PD, Johnstone SR, MacDermot J.

Br J Pharmacol. 2001 Aug;133(8):1219-26.

4.

Food-derived heterocyclic amine mutagens: variable metabolism and significance to humans.

Gooderham NJ, Murray S, Lynch AM, Yadollahi-Farsani M, Zhao K, Boobis AR, Davies DS.

Drug Metab Dispos. 2001 Apr;29(4 Pt 2):529-34.

PMID:
11259345
5.

Arginine-specific ADP-ribosyltransferase of human polymorphonuclear neutrophil leucocytes: cDNA cloning and identification of a polymorphic site in the coding region.

Kefalas P, Yadollahi-Farsani M, Saxty BA, MacDermot J.

Biochem Soc Trans. 1998 Feb;26(1):S81. No abstract available.

PMID:
10909839
6.

Stable expression for investigation of possible differential activity of two polymorphic forms of the human arginine specific ADP-ribosyltransferase.

Yadollahi-Farsani M, Kefalas P, Saxty BA, MacDermot J.

Biochem Soc Trans. 1998 Feb;26(1):S80. No abstract available.

PMID:
10909838
7.
8.

Chemotaxin-dependent translocation of immunoreactive ADP-ribosyltransferase-1 to the surface of human neutrophil polymorphs.

Kefalas P, Saxty B, Yadollahi-Farsani M, MacDermot J.

Eur J Biochem. 1999 Feb;259(3):866-71.

9.

Inhibition of chemotaxis in A7r5 rat smooth muscle cells by a novel panel of inhibitors.

Saxty BA, Yadollahi-Farsani M, Kefalas P, Paul S, MacDermot J.

Br J Pharmacol. 1998 Sep;125(1):152-8.

10.

ADP-ribosyltransferase inhibitors and pseudo-substrates inhibit rat smooth muscle cell migration in vitro.

Saxty B, Yadollahi-Farsani M, Kefalas P, Paul S, MacDermot J.

Biochem Soc Trans. 1998 May;26(2):S130. No abstract available.

PMID:
9649805
11.

Molecular mechanisms of mutagen hypersensitivity in adenine phosphoribosyl transferase-deficient Friend mouse erythroleukaemia cells.

Yadollahi-Farsani M, McKenna PG, McKelvey-Martin VJ.

Br J Biomed Sci. 1997 Sep;54(3):174-80.

PMID:
9499594
12.

Arginine-specific ADP-ribosyltransferases in leukocytes.

Saxty BA, Kefalas P, Yadollahi-Farsani M, MacDermot J.

J Leukoc Biol. 1998 Jan;63(1):15-21. Review.

PMID:
9469468
13.

Assessing human risk to heterocyclic amines.

Gooderham NJ, Murray S, Lynch AM, Yadollahi-Farsani M, Zhao K, Rich K, Boobis AR, Davies DS.

Mutat Res. 1997 May 12;376(1-2):53-60.

PMID:
9202738
14.

Arginine-specific mono(ADP-ribosyl)transferase activity in human neutrophil polymorphs. A possible link with the assembly of filamentous actin and chemotaxis.

Kefalas P, Allport JR, Donnelly LE, Rendell NB, Murray S, Taylor GW, Lo G, Yadollahi-Farsani M, MacDermot J.

Adv Exp Med Biol. 1997;419:241-4. Review.

PMID:
9193659
15.

A possible role for mono (ADP-ribosyl) transferase in the signalling pathway mediating neutrophil chemotaxis.

Allport JR, Donnelly LE, Kefalas P, Lo G, Nunn A, Yadollahi-Farsani M, Rendell NB, Murray S, Taylor GW, MacDermot J.

Br J Clin Pharmacol. 1996 Jul;42(1):99-106.

16.

Heterocyclic amines: evaluation of their role in diet associated human cancer.

Gooderham NJ, Murray S, Lynch AM, Edwards RJ, Yadollahi-Farsani M, Bratt C, Rich KJ, Zhao K, Murray BP, Bhadresa S, Crosbie SJ, Boobis AR, Davies DS.

Br J Clin Pharmacol. 1996 Jul;42(1):91-8. Review.

17.

Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine(PhIP) at the Chinese hamsters hprt locus.

Yadollahi-Farsani M, Gooderham NJ, Davies DS, Boobis AR.

Carcinogenesis. 1996 Apr;17(4):617-24.

PMID:
8625468
18.

Enzymic and interindividual differences in the human metabolism of heterocyclic amines.

Boobis AR, Gooderham NJ, Edwards RJ, Murray S, Lynch AM, Yadollahi-Farsani M, Davies DS.

Arch Toxicol Suppl. 1996;18:286-302. Review.

PMID:
8678804

Supplemental Content

Loading ...
Support Center